JQDN

General

Comparative Effectiveness Of Amiodarone And Lidocaine For The

Di: Stella

For patients with IHCA and shock-refractory VF/pVT, the adoption of an amiodarone-first strategy seemed to be associated with the termination of VF/pVT using fewer shocks. Nonetheless, because of the small sample size, additional large-scale studies should be conducted to investigate whether this ad Lidocaine has been the initial antiarrhythmic drug treatment recommended for patients with ventricular fibrillation that is resistant to conversion by defibrillator shocks. We performed a randomize

Table of Contents page: CHEST

Compared with amiodarone, lidocaine therapy among adult patients with in-hospital cardiac arrest from VT/VF was associated with statistically significantly higher rates of ROSC, 24 h survival, survival to hospital discharge, and favorable neurologic outcome.

Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular ...

Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest. Chest. 2023 May;163(5):1109-1119. https://pubmed.ncbi.nlm.nih.gov/36332663/ Holmberg MJ, Ross CE, Atkins DL, et al; American Heart Association’s for the AHA’s Get With The Guidelines®-Resuscitation Pediatric Research they form a unique fingerprint Task Force. The use of lidocaine and amiodarone for patients with OHCA due to shockable rhythms within a real-world setting showed no significant differences in short-term mortality or neurological outcome. There is no evidence that either amiodarone or lidocaine is superior in treatment; thus, either or both d

The most oft-cited study when it comes to this conundrum is the Amiodarone, Lidocaine, or Placebo (ALPS) study of 3,026 patients, published by the Resuscitation Outcomes Consortium in 2016, which assessed the efficacy of amiodarone (974), lidocaine (993), or saline placebo (1059) administration by paramedics in non-traumatic out-of-hospital cardiac arrests with focus on Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest journal.chestnet.org 4 1 commentaire Partager Kurt Rehagen When compared to placebo, both amiodarone and lidocaine were associated with a statistically significant increase in survival to hospital admission. Lidocaine was superior to both placebo and bretylium for ROSC.

Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest journal.chestnet.org 4 1 Comment Kurt Rehagen Comparative Effectiveness of Amiodarone and Lidocaine for Treatment of In – Hospital Cardiac Arrest

Amiodarone v. Lidocaine: Versus Series References

PubMed Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest. Wagner D, Kronick SL, Nawer H, Cranford JA, Bradley SM, Neumar RWChest 2023 May;163 (5):1109-1119. Epub 2022 Nov 2 doi: 10.1016/j.chest.2022.10.024. PMID: 36332663 Criteria for Defining Stages of Cardiogenic Shock Severity. Guidelines recommend amiodarone or lidocaine based on multiple trials of out-of-hospital cardiac arrest (OHCA). However, in-hospital cardiac arrests (IHCAs) are often different from OHCAs with regard to inciting cause, response times, and other factors.

Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest. Chest. 2023 May;163 (5):1109-1119. doi: 10.1016/j.chest.2022.10.024.

Compared with amiodarone, lidocaine therapy among adult patients with in-hospital cardiac inhaftieren off VT/VF was associated for statistically significantly bigger rates for ROSC, 24 h survival, survival to hospital discharge, and favorable neurologic outcome. Recent International Liaison Committee on Resuscitation guidelines on resuscitation recommend amiodarone and lidocaine as the treatment of choice for OHCA patients with ventricular fibrillation/pulseless ventricular tachycardia Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest journal.chestnet.org 4 1 Comment Kurt Rehagen

true[Article] Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest Fingerprint Dive into the research topics of ‚Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest‘. Together they form a unique fingerprint.

Download Citation | Comparison the efficacy of amiodarone and lidocaine for cardiac arrest: A network meta-analysis | Background: There is no evidence that antiarrhythmic drugs can improve long Request PDF | Comparative Effectiveness of Amiodarone and Lidocaine for Treatment of In-Hospital Cardiac Arrest (IHCA) | Background American Heart Association (AHA) Advanced Cardiac Life Support Clinical prediction guides Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest. Wagner D, Kronick SL, Nawer H, Cranford JA, Bradley SM, Neumar RWChest 2023 May;163 (5):1109-1119. Epub 2022 Nov 2 doi: 10.1016/j.chest.2022.10.024. PMID: 36332663 In-hospital cardiac arrest: the state of the art.

Recent underpowered evidence suggests that amiodarone, lidocaine or placebo are equivalent with respect to survival at hospital discharge, but amiodarone and lidocaine showed higher hospital admission rates. We undertook a systematic review and meta-analysis to assess efficacy of amiodarone vs lidocaine vs placebo.

In-Hospital Cardiac Arrest

Compare with amiodarone, lidocaine therapy amidst adult patients with in-hospital cardiac arrest from VT/VF what associated with statistically significantly higher rates of ROSC, 24 h survival, survival to hospital discharge, and favorable neurologic outcome. Conclusions: Amiodarone had the best effect on both first line survival to hospital admission, discharge and more favorable neurological outcome. Thus, amiodarone should be listed as first line drug for cardiac arrest. However, the quality of available evidence limits the formation of powerful conclusions regarding the comparative efficacy or safety of amiodarone

Aim of the study: The aim of this study is to systematically review and compare the efficacy of lidocaine and amiodarone in the treatment of cardiac arrest due to ventricular fibrillation and ventricular tachycardia in adults. This review seeks to evaluate the existing literature to determine the effectiveness and clinical outcomes associated with each medication. Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest. Deborah Wagner, S L Kronick, H Nawer, J A Cranford, S M Bradley, R W Neumar Amiodarone and lidocaine were the only agents associated with improved survival to hospital admission in the NMA. For the outcomes most important to patients, survival to hospital discharge and neurologically intact survival, no antiarrhythmic was convincingly superior to

REFERENCE Wagner D, Kronick SL, Nawer H, Cranford JA, Bradley SM, Neumar RW. Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of: In-Hospital Cardiac Arrest. Chest. Published online November 2, 2022:S0012-3692(22)04039-9. Background American Heart Association Advanced Cardiac Life Support (ACLS) guidelines support the use of either amiodarone or lidocaine for cardiac arrest caused by ventricular tachycardia or ventricular fibrillation (VT/VF) based on studies of out-of-hospital cardiac arrest. Studies comparing amiodarone and lidocaine in adult populations with in-hospital VT/VF arrest Wagner D et al. Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of: In-Hospital Cardiac Arrest. Chest. 2022 Nov 2;S0012-3692 (22)04039-9. doi: 10.1016/j.chest.2022.10.024.Online ahead of print Ali MU, et

Valdes, Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation, Resuscitation, № 85, с. 381

? 科研通第二届『应助活动周』正在进行中，3月24-30日求助秒级响应?，千元现金等你拿。 当前排名? ? 中科院2025期刊分区? 已更新

Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest Deborah Wagner, S.L. Kronick, H. Nawer, J.A. Cranford, S.M. Bradley, R.W. Neumar Published online: November 01, 2022 p1109-1119 Full-Text HTML PDF Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest Deborah Wagner, PharmD, S.L. Kronick, MD, H. Nawer, PharmD, J.A. Cranford, PhD, S.M. Bradley, MD, PhD, R.W. Neumar, MD, PhD CHEST Volume 163

Regarding the Comparative Effectiveness of Lidocaine and Amiodarone for Treatment of In-Hospital Cardiac Arrest.

Semantic Scholar extracted view of „Comparative Effectiveness of Amiodarone and Lidocaine for Treatment of In-Hospital Cardiac Arrest (IHCA).“ by D. Wagner et al. 已完结 文献求助详情 标题 Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest 胺碘酮与利多卡因治疗院内心脏骤停的疗效比较 相关领域 医学 胺碘酮 利多卡因 心室颤动 心肺复苏术 除颤 自然循环恢复 麻醉 内科学 心脏病学 高级心脏生命支持 抗心律失常药 优势比 回顾性